Aspartate aminotransferase-to-platelet ratio index is a powerful predictor of mortality among HIV-positive patients

Journal of Infectious Diseases

Volumn 207, Issue 2, 2013, Pages 367-368

  Post, Frank A ^a   Sabin, Caroline A ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; VIRUS RNA;

ANALYTIC METHOD; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; CD4+ T LYMPHOCYTE; DISEASE SEVERITY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LIVER FIBROSIS; MIXED INFECTION; MORTALITY; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; THROMBOCYTE COUNT; UNITED KINGDOM; VIRUS LOAD;

EID: 84871727968     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis666     Document Type: Letter

References (8)

1. Price JC, Seaberg EC, Badri S, Witt MD, D'Acunto K, Thio CL. HIV monoinfection is associated with increased aspartate amino-transferase-to- platelet ratio index, a surrogate marker for hepatic fibrosis. J Infect Dis 2012; 205:1005-13.
2. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38:518-26.
3. The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study. HIV Med 2004; 5:115-24.
4. Merchante N, Perez-Camacho I, Mira JA, et al. Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine. Antivir Ther 2010; 15:753-63.
5. Vergara S, Macias J, Rivero A, et al. The use of transient elastometry for assessing liver fi-brosis in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis 2007; 45:969-74.
6. Al-Mohri H, Murphy T, Lu Y, Lalonde RG, Klein MB. Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker. J Acquir Immune Defic Syndr 2007; 44:463-9.
7. Jain MK, Seremba E, Bhore R, et al. Change in fibrosis score as a predictor of mortality among HIV-infected patients with viral hepatitis. AIDS Patient Care STDS 2012; 26:73-80.
8. Bambha K, Pierce C, Cox C, et al. Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis. AIDS 2012; 26:599-607.